KMI
67
-2
WAT
55
2
WEC
53
-2
SYY
53
4
DVN
21
3
FITB
63
3
STI
14
-17
F
58
11
ILMN
42
5
HSIC
56
5
DFS
64
2
VFC
53
5
BF.B
33
2
KEY
46
3
CL
58
2
TSCO
49
5
MLM
57
6
AXP
71
2
UA
50
-9
MRK
25
-2
KMI
67
-2
WAT
55
2
WEC
53
-2
SYY
53
4
DVN
21
3
FITB
63
3
STI
14
-17
F
58
11
ILMN
42
5
HSIC
56
5
DFS
64
2
VFC
53
5
BF.B
33
2
KEY
46
3
CL
58
2
TSCO
49
5
MLM
57
6
AXP
71
2
UA
50
-9
MRK
25
-2
Financhill
Back

Heron Therapeutics 10K Form

Sell
15

HRTX
Heron Therapeutics

Last Price:
1.07
Seasonality Move:
17.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRTX News And Ratings

See the #1 stock for the next 7 days that we like better than HRTX

HRTX Financial Statistics

Sales & Book Value

Annual Sales: $127.04M
Cash Flow: $2.94M
Price / Cash Flow: 0
Annual Sales: $-0.26
Price / Book: 0

Profitability

EPS (TTM): -0.16000
Net Income (TTM): $-27.97M
Gross Margin: $61.94M
Return on Equity: 0%
Return on Assets: -12.62%

Heron Therapeutics Earnings Forecast

Key Heron Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 37 years for HRTX is 48.75%.
  • The Selling, General & Administrative Expenses for HRTX have been equal to 91.82% of Gross Profit Margin.
  • The Research & Development expenses have been 44.00% of Revenue.
  • The Interest Expense is -3.50% of Operating Income.
  • The Net Earning history of HRTX is -87.02% of Total Revenues.
  • Per Share Earnings over the last 37 years have been positive in 20 years.

Heron Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: HRTX
CUSIP: 427746
Website: herontx.com

Debt

Debt-to-Equity Ratio: -4.36
Current Ratio: 2.28
Quick Ratio: 1.61

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HRTX Technical Analysis vs Fundamental Analysis

Sell
15
Heron Therapeutics (HRTX) is a Sell

Is Heron Therapeutics a Buy or a Sell?